Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2012
10/31/2012CN102757494A Preparation method of chicken egg yolk antibody against duck flavivirus
10/31/2012CN102757493A Method for preparing chicken pox virus antibody
10/31/2012CN102757492A Holistic hepatitis B surface protein monoclonal antibodies and application thereof to preparation of medicines for preventing HBV (hepatitis B virus) infection
10/31/2012CN102757481A Function epitopes of staphylococcal enterotoxin B (SEB), monoclonal antibodies specifically bound with function epitopes and application of monoclonal antibodies
10/31/2012CN102757480A Anti-dengue virus type-4 neutralizing epitope-specific antibody and application of anti-dengue virus type-4 neutralizing epitope-specific antibody to treatment of dengue virus type-4 infection
10/31/2012CN102757391A Phenobarbital derivative and preparation method and application thereof
10/31/2012CN102755646A Medicament for treating TNF alpha related disorder
10/31/2012CN102754623A Method for acquiring ricedrawfvirus (RDV) by utilizing nephotettix cincticeps under artificial conditions and application of RDV
10/31/2012CN101972478B 抗体治疗 Antibody therapy
10/31/2012CN101687925B Engineered anti-IL-23p19 antibodies
10/31/2012CN101563365B Anti-IL-6 monoclonal antibodies and uses thereof
10/31/2012CN101262884B Anti A beta antibody formulation
10/31/2012CN101107269B Monoclonal antibodies against NKG2A
10/31/2012CN101035808B Humanized anti-CMET antagonists
10/30/2012US8299230 Nucleic acid molecules encoding antibodies that bind cell-associated CA 125/O772P
10/30/2012US8299222 Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
10/30/2012US8299220 Isolation of five novel genes coding for new Fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma
10/30/2012US8299219 Polypeptides, polynucleotides encoding same, antibodies thereagainst and methods of using same for diagnosing and treating cancer and skeletal disorders
10/30/2012US8299218 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
10/30/2012US8299213 Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses
10/30/2012US8299129 Peptide lipid-containing carrier and method for introducing compound into cells using same
10/30/2012US8299020 Antimicrobial peptides and methods of their use
10/30/2012US8298836 For forming an immune complex with an antigen in an analytical sample and being modified by adding an amino acid sequence comprising a charged amino acid residue and by being labeled with a fluorescent dye
10/30/2012US8298799 Hydrolases, nucleic acids encoding them and methods for making and using them
10/30/2012US8298783 Detecting molecules
10/30/2012US8298771 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
10/30/2012US8298770 Methods, kits, and antibodies for detecting parathyroid hormone
10/30/2012US8298769 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
10/30/2012US8298757 Rapid diagnosis method specific to avian influenza virus
10/30/2012US8298540 Methods of modulating T cell-mediated immune responses with anti-P-selectin glycoprotein ligand 1 antibodies
10/30/2012US8298537 Concomitant treatment of rheumatoid arthritis with anti-TNF-α antibodies and methotrexate
10/30/2012US8298536 Methods of treating inflammatory pain
10/30/2012US8298535 Anti-IL-7 receptor antibodies
10/30/2012US8298534 Method of treating fibrproliferative disorders
10/30/2012US8298533 Antibodies to IL-1R1
10/30/2012US8298532 Fusion polypeptides capable of activating receptors
10/30/2012US8298530 Stable lyophilized pharmaceutical formulation of IgG antibodies
10/30/2012US8298525 Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist
10/30/2012CA2595038C Modified tie-2 receptor ligands
10/30/2012CA2525184C Il-23p40 specific immunoglobulin derived proteins, compositions, methods and uses
10/30/2012CA2411374C Dual specificity antibodies and methods of making and using
10/30/2012CA2395617C Trichoderma reesei xylanase
10/30/2012CA2375868C Stabilized denatured lipoprotein and method for producing thereof
10/30/2012CA2360106C Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
10/30/2012CA2230111C Antisecretory factor peptides regulating pathological permeability changes
10/30/2012CA2215161C Proteinase k resistant surface protein of neisseria meningitidis
10/29/2012CA2741110A1 Compositions and methods for determining genetic polymorphisms in the tmem216 gene
10/26/2012WO2012145673A1 Antibody polypeptides that antagonize cd40
10/26/2012WO2012145666A1 Peptide and conjugate vaccines for fungal infections
10/26/2012WO2012145507A2 Monospecific and bispecific anti-igf-1r and anti-erbb3 antibodies
10/26/2012WO2012145493A1 Antibodies and other molecules that bind b7-h1 and pd-1
10/26/2012WO2012145469A1 Human monoclonal antibodies specific for glypican-3 and use thereof
10/26/2012WO2012145183A2 Combinations of anti-4-1bb antibodies and adcc-inducing antibodies for the treatment of cancer
10/26/2012WO2012144784A2 Monoclonal antibodies which specifically recognize human liver-carboxylesterase 1, hybridoma cell lines which produce monoclonal antibodies, and uses thereof
10/26/2012WO2012144692A1 Humanized anti-emap ii antibody and use thereof
10/26/2012WO2012144579A1 Antibody preparation having solution form
10/26/2012WO2012144208A1 Diagnosis and treatment of cancer using anti-itm2a antibody
10/26/2012WO2012143902A1 Compositions relating to a mutant clostridium difficile toxin and methods thereof
10/26/2012WO2012143524A2 Bispecific antibodies against her2 and cd3
10/26/2012WO2012143523A1 Bispecifc antibodies against her2
10/26/2012WO2012143516A1 Amplification of regulatory t cells by means of anti-thymocyte immunoglobulins with cytokine, inhibitor of tor protein kinase and/or differentiating agent
10/26/2012WO2012143499A2 Novel binder-drug conjugates (adcs) and their use
10/26/2012WO2012143498A1 Bcma-based stratification and therapy for multiple myeloma patients
10/26/2012WO2012143496A2 Novel binder-drug conjugates (adcs) and their use
10/26/2012WO2012143495A2 Novel binder-drug conjugates (adcs) and their use
10/26/2012WO2012143488A1 Protein for use as a medicament
10/26/2012WO2012143484A1 Method for preparing a depleted plasma material consisting of one or more thrombogenic factors
10/26/2012WO2012143382A2 Gpr177 as target and marker in tumors
10/26/2012WO2012143380A1 Microwaves for immunohistochemical analysis
10/26/2012WO2012143379A1 Method and constructs for the ph dependent passage of the blood-brain-barrier
10/26/2012WO2012142899A1 Anti-cyanobacteria recombinant antibody polypeptide, gene thereof, and preparation method thereof
10/26/2012WO2012142662A1 Modified variable domain molecules and methods for producing and using them b
10/26/2012WO2012142659A1 Site-selective modification of proteins
10/26/2012WO2012118974A3 Detection of human endogenous retrovirus expression in cancer and normal cells
10/26/2012WO2012108650A3 Uses of a monoclonal antibody to proteinase-3 as a therapeutic agent or as a diagnostic agent for a stroke
10/26/2012WO2012107728A3 Frmd4a antagonists and their uses
10/26/2012WO2012074966A3 Improved production of anti-peptide antibodies
10/26/2012WO2012049431A3 Use of an anti-cd20 antibody for treating primary cerebral lymphoma
10/26/2012WO2012024659A3 Antibody-based constructs directed against tyrosine kinase receptors
10/26/2012CA2833793A1 Anti-cyanobacteria recombinant antibody polypeptide, gene thereof, and preparation method thereof
10/26/2012CA2833743A1 Antibody polypeptides that antagonize cd40
10/26/2012CA2833690A1 Novel binder-drug conjugates (adcs) and their use
10/26/2012CA2833643A1 Monospecific and bispecific anti-igf-1r and anti-erbb3 antibodies
10/26/2012CA2833636A1 Antibodies and other molecules that bind b7-h1 and pd-1
10/26/2012CA2833477A1 Novel binder-drug conjugates (adcs) and their use
10/26/2012CA2833404A1 Modified variable domain molecules and methods for producing and using them b
10/26/2012CA2833295A1 Analyzing the expression of biomarkers in cells with clusters
10/26/2012CA2833019A1 Prostate-specific membrane antigen binding proteins and related compositions and methods
10/26/2012CA2832712A1 Compositions relating to a mutant clostridium difficile toxin and methods thereof
10/26/2012CA2832510A1 Bcma-based stratification and therapy for multiple myeloma patients
10/26/2012CA2832389A1 Bispecific antibodies against her2 and cd3
10/26/2012CA2832387A1 Bispecifc antibodies against her2
10/26/2012CA2830972A1 Combinations of anti-4-1bb antibodies and adcc-inducing antibodies for the treatment of cancer
10/26/2012CA2828662A1 Method and constructs for the ph dependent passage of the blood-brain-barrier
10/25/2012US20120271040 Mammalian expression vector
10/25/2012US20120271035 T1r taste receptors and genes encoding same
10/25/2012US20120271034 Antigenic determinants recognized by anti-human death receptor dr5 monoclonal antibody ad5-10, derivatives and uses thereof
10/25/2012US20120270940 Closthioamides
10/25/2012US20120270923 Natriuretic peptide receptor as a biomarker for diagnosis and prognosis of cancer
10/25/2012US20120270809 Human transmembrane proteins
1 ... 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 ... 1494